Using a large Japanese real‐world database, we examined antidiabetic drug selection in first and second therapy stratified by renal function and study period. The earlier initiation of SGLT2 inhibitors and GLP‐1 receptor agonists increased over time, particularly in second therapy, with prescribing patterns increasingly aligned across renal function ...
Masashi Kubota +2 more
wiley +1 more source
An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction. [PDF]
Kobayashi M +9 more
europepmc +1 more source
An overlap between proteomic and transcriptomic findings in experiments testing brain responses to glucocorticoids. A shows that 455 proteins responsive to glucocorticoids were not confirmed at the transcriptomic level while 4 proteins were matched with significant differences in mRNA in all 8 datasets derived from transcriptomic experiments.
Grzegorz R. Juszczak
wiley +1 more source
Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors? [PDF]
Komiyama M, Hasegawa K, Rosano GMC.
europepmc +1 more source
Distinct Effects of Maternal Stress and Exercise on Offspring Metabolic Health
Maternal exercise improves glucose tolerance in adult male offspring, but this benefit is blunted by maternal stress. Exercise increases offspring corticosterone levels independent of stress, whereas maternal stress upregulates glucocorticoid and mineralocorticoid receptor expression in brown adipose tissue, which is prevented by maternal exercise ...
Felix T. Yang +10 more
wiley +1 more source
Efficacy and safety of mineralocorticoid receptor antagonists in kidney transplant patients: an updated meta-analysis of randomized controlled trials. [PDF]
Dibo P +6 more
europepmc +1 more source
Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical Practice. [PDF]
Alfarano M +10 more
europepmc +1 more source
Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study. [PDF]
Svanström H +3 more
europepmc +1 more source
Comparing the Long-Term Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors Versus Mineralocorticoid Receptor Antagonists as Add-On Therapies in the Management of Heart Failure: A Systematic Review. [PDF]
George V +5 more
europepmc +1 more source
In Silico Investigation of Mineralocorticoid Receptor Antagonists: Insights into Binding Mechanisms and Structural Dynamics. [PDF]
Liang JJ +6 more
europepmc +1 more source

